These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15086604)
1. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis. Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604 [TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma. Wu GS; Wang JH; Liu ZR; Zou SQ Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721 [TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729 [TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma. Choi HJ; Kim HJ; Choi JH Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664 [TBL] [Abstract][Full Text] [Related]
6. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma. Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088 [TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma. Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413 [TBL] [Abstract][Full Text] [Related]
10. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
11. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
12. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054 [TBL] [Abstract][Full Text] [Related]
13. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Zhao P; Lu Y; Zhong M; Liu L; Li B Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300 [TBL] [Abstract][Full Text] [Related]
14. Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma. Miwa S; Soeda J; Miyagawa S Hepatogastroenterology; 2005; 52(65):1398-402. PubMed ID: 16201082 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract. Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407 [TBL] [Abstract][Full Text] [Related]
18. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Masunaga R; Kohno H; Dhar DK; Ohno S; Shibakita M; Kinugasa S; Yoshimura H; Tachibana M; Kubota H; Nagasue N Clin Cancer Res; 2000 Oct; 6(10):4064-8. PubMed ID: 11051257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]